Strong Earnings Performance#
Acadia Healthcare Company Inc. reported solid financial results for the first quarter of 2026. The company achieved earnings per share (EPS) of $0.37, which is significantly higher than the expected $0.26, marking a 42.31% surprise. Additionally, Acadia's revenue reached $828.8 million, slightly above the forecast of $822.91 million, reflecting a year-over-year growth of 7.6%.
Revenue Growth Drivers#
The growth in revenue was primarily driven by the company's acute inpatient psychiatric facilities, which saw a remarkable 14.2% increase in revenue due to higher patient volumes. However, Acadia faced challenges in its Pennsylvania specialty facilities and was also impacted by adverse weather conditions, which affected performance in other segments.
Market Reaction#
Despite the positive earnings report, Acadia's stock fell by 21.85% in premarket trading, dropping to $27.06. The decline continued, with the stock reaching $22.12, resulting in a market capitalization of approximately $2.03 billion. This drop suggests that investors may have concerns about operational challenges and broader market conditions, even though some analyses indicate that the stock might be undervalued at its current levels.
Future Outlook#
Looking ahead, Acadia is focused on expanding its capacity, with plans to add between 400 to 600 new beds in 2026. The company remains optimistic about its growth prospects, supported by strategic partnerships and ongoing facility developments. Analysts project earnings of $1.46 per share for fiscal 2026, although some have recently revised their estimates downward. Acadia's CEO, Debbie Osteen, emphasized the company's commitment to navigating these challenges while pursuing growth.